Suchergebnisse

The aim of the present study was to demonstrate cases of cost‐benefit analysis within healthcare, of how economic factors can be considered in occupational radiological protection, in agreement with the as low as reasonably achievable principle and present Swedish legislations. In the first part of the present study, a comparison of examples within health economics used by authorities and institutes in Sweden was made. The comparison focused on value of a statistical life, quality‐adjusted life year, and monetary cost assigned to a unit of collective dose for radiation protection purposes (α‐value). By this comparison, an α‐value was determined as an interval between $45 and $450 per man‐mSv, for the Swedish society in 2021. The α‐value interval can be interpreted as following: 1. Less than $45 per man‐mSv is a good investment. 2. From $45 to $450 per man‐mSv, other factors than costs and collective dose are important to consider. 3. More than $450 per man‐mSv is too expensive. In the second part of the present study, seven cases of cost‐benefit analyses in occupational radiological protection were provided. The present study focused specifically on cases where the relevant factors were costs and collective dose. The present case study shows a large variation in costs per collective dose from different types of occupational radiological protection, used at Skaraborg Hospital in Sweden.